Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer

by | Jan 1, 2020 | Publicaciones - CIMO-02 | 0 comments

Hanna, GJ; Guenette, JP; Chau, NG; Sayehli, CM; Wilhelm, C; Metcalf, R; Wong, DJ; Brose, M; Razaq, M; Perez-Ruiz, E; Cohen, EEW; Aggarwal, R; Scholz, C; Gualberto, A; Ho, AL – 2020